CORT Q2 2017 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+80.3% YoY

Gross Profit

$35M97.8% margin

Operating Income

$13M36.0% margin

Net Income

$13M35.6% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+28.8%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$87M

Total Liabilities

$20M

Stockholders' Equity

$66M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$20M	+80.3%
Gross Profit	$35M	$19M	+80.2%
Operating Income	$13M	$2M	+748.5%
Net Income	$13M	$977,000	+1194.5%